Can pharmacists help end HIV? new study trains louisiana pharmacists to prescribe PrEP
NCT ID NCT06530225
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will train 75 Louisiana pharmacists to prescribe PrEP, a daily pill that prevents HIV. The training includes lessons on health disparities and implicit bias, plus mentoring. Researchers want to see if this increases the number of PrEP prescriptions, especially in communities that often miss out on HIV prevention.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Education and mentoring program for pharmacists
What this could lead to
If successful, this could expand PrEP access in Louisiana and reduce HIV infection rates, especially in underserved communities.
What could go wrong
This is a small, early-stage study (75 pharmacists) focused on training, not patient outcomes. It may not show a direct impact on HIV prevention or be scalable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Xavier University of Louisiana
New Orleans, Louisiana, 70125, United States